TRIO
DEAD

Serial Number

98178586

Owner

SassyCam LLC

Attorney

Kim Cooper

Filing Date

Sep 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

TRIO Trademark

Serial Number: 98178586

TRIO is a trademark filed by SassyCam LLC on September 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

SassyCam LLC

2300 West Sahara Avenue
Las Vegas, NV 89102

Entity Type: 16

Trademark Details

Filing Date

September 13, 2023

Registration Date

Not Registered

Goods & Services

Direct-to-consumer diagnostic test kits comprising a downloadable software application for use in analyzing microbiome, fertility, hormone, and biomarker testing of humans; scientific research specimen collection devices in the nature of cartridges and rigid and semi-rigid containers for the collection of saliva and bodily fluids for use in analyzing microbiome, fertility, hormone, and biomarker testing of humans; laboratory storage test cartridges used to store laboratory samples for use in analyzing microbiome, fertility, hormone, and biomarker testing of humans; medical laboratory research instruments for testing of bodily fluids and detecting the levels of biomarkers; downloadable software for health and medical data storage, data analysis, and report generation for analyzing microbiome, fertility, hormone, and biomarker information; downloadable software for recording, storing, and organizing cellular, molecular, physiological, and medical data for analyzing microbiome, fertility, hormone, and biomarker information; downloadable software for analyzing microbiome, fertility, hormone, and biomarker information for medical diagnostic purposes; downloadable software for display and communication of medical information, remote patient monitoring and providing telehealth and digital medical services for analyzing microbiome, fertility, hormone, and biomarker information; none of the aforesaid relating to thermal analysis and rheology instruments

Diagnostic at-home health test and screening kits comprised of medical diagnostic reagents for testing of bodily fluids for use in determining the presence of medical conditions and levels of biomarkers; diagnostic test cartridges in the nature of diagnostic test reagents for medical purposes for use in determining the presence of medical conditions and levels of biomarkers; direct-to-consumer diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in microbiome, fertility, hormone, and biomarker testing of humans; none of the aforesaid relating to thermal analysis and rheology instruments

Medical diagnostic testing, monitoring and reporting services, namely, providing testing, monitoring and reporting services using self-collected samples outside of a clinical laboratory setting; providing medical information in the field of microbiome, fertility, hormone, and biomarker testing of humans; none of the aforesaid relating to medical and clinical research in the field of oncology; none of the aforesaid relating to thermal analysis and rheology instruments

Direct-to-consumer medical diagnostic test kits comprised of probes, buffers, and reagents for use in microbial testing and microbiome, fertility, hormone, and biomarker testing of humans; medical testing apparatus, instruments, and devices for diagnostic use, namely, apparatus, instruments, and devices for medical diagnostic testing through the collection and analysis of body fluids, biomarkers, fertility, and hormone levels; medical instruments for taking samples for review for medical diagnostic purposes; lab test cartridges for medical testing purposes; medical devices, instruments, and apparatus for obtaining body fluid samples; saliva collection devices for medical purposes; sterile medical specimen collection tools in the nature of cartridges and rigid and semi-rigid containers for the collection of saliva and bodily fluids; none of the aforesaid relating to thermal analysis and rheology instruments

Providing scientific research information and analysis in the fields of microbiomes, fertility, hormone levels, and biomarkers; providing medical research information in the field of testing results for medical conditions; Software as a Service (SaaS) featuring software for health and medical data storage, data analysis, and report generation for medical diagnostic purposes; Software as a Service (SaaS) featuring software for recording, storing, and organizing cellular, physiological and molecular data for medical diagnostic purposes; Software as a Service (SaaS) featuring software for analyzing microbiome, fertility, hormone, and biomarker information for medical diagnostic purposes; Software as a Service (SaaS) featuring software for display and communication of medical information, remote patient monitoring and providing telehealth and digital medical services; none of the aforesaid relating to medical and clinical research in the field of oncology; none of the aforesaid relating to thermal analysis and rheology instruments

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 17, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 17, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 26, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 26, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 29, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 6, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 9, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 9, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 9, 2024 CNRT
ASSIGNED TO EXAMINER
May 8, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 3, 2023 NWOS
NEW APPLICATION ENTERED
Sep 16, 2023 NWAP